| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 183.474 | 276.195 | 609.054 | 638.754 | 556.720 |
| Total Income - EUR | - | - | - | - | - | 183.545 | 276.616 | 612.020 | 648.650 | 574.148 |
| Total Expenses - EUR | - | - | - | - | - | 80.682 | 163.822 | 288.153 | 378.320 | 321.670 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 102.863 | 112.794 | 323.867 | 270.329 | 252.478 |
| Net Profit/Loss - EUR | - | - | - | - | - | 100.772 | 110.028 | 318.396 | 254.910 | 213.207 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Oxcart Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 11 | 20.335 | 28.641 | 71.758 | 60.345 |
| Current Assets | - | - | - | - | - | 147.849 | 187.941 | 599.838 | 296.020 | 375.022 |
| Inventories | - | - | - | - | - | 18.180 | 26.960 | 32.647 | 34.654 | 127.720 |
| Receivables | - | - | - | - | - | 87.507 | 127.132 | 437.227 | 137.065 | 151.486 |
| Cash | - | - | - | - | - | 42.162 | 33.849 | 129.964 | 124.301 | 95.816 |
| Shareholders Funds | - | - | - | - | - | 100.813 | 161.787 | 318.445 | 303.539 | 225.042 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 47.084 | 46.806 | 310.824 | 64.898 | 212.867 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Oxcart Medical S.r.l.